Bowel symptoms associated with coronavirus disease 19 in hospitalized patients with moderate to severe illness
DOI:
https://doi.org/10.31686/ijier.vol10.iss12.4011Keywords:
Diarrhea, COVID-19, Constipation, Surveys and QuestionnairesAbstract
Bowel symptoms, such as diarrhea, have higher prevalence during coronavirus disease 2019 (COVID-19). The correlation between the severity of these symptoms and their prognosis has not been defined yet. Furthermore, higher prevalence of gastrointestinal symptoms after recovery from COVID-19 has been reported. This study aimed to analyze the correlation of potential factors with the severity of diarrhea during COVID-19 and to assess the progression of post-COVID-19 bowel symptoms. This prospective longitudinal cohort included 109 patients with moderate to severe COVID-19 symptoms who were hospitalized from May to July 2021. Patients were interviewed to assess the presence and intensity of bowel symptoms during COVID-19 and 3–6 months after hospital discharge using the Gastrointestinal Symptom Rating Scale questionnaire. Demographic and clinical data were obtained and their correlations with the intensity of bowel symptoms were examined. The presence of severe diarrhea was correlated with the need for ventilatory support and the use of anticoagulants but not with the use of antibiotics. In addition, bowel symptoms, such as loose stools and incomplete evacuation but not diarrhea, constipation, or abdominal pain, persisted for at least 3–6 months after hospital discharge. These results suggest that the severity of diarrhea during COVID-19 may be associated with worsening of the disease and that only loose stools and incomplete evacuation are present after COVID-19. The chronicity of these bowel symptoms should be evaluated to improve the treatment of patients with COVID-19.
Downloads
References
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., et al. (2020). Extrapulmonary manifestations of COVID-19. Nature medicine, 26(7), 1017-1032. doi: 10.1038/s41591-020-0968-3.
Livanos, A. E., Jha, D., Cossarini, F., Gonzalez-Reiche, A. S., Tokuyama, M., Aydillo, T., et al. (2021). Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms. Gastroenterology, 160: 2435-2450.e.34. doi: 10.1053/j.gastro.2021.02.056.
Nobel, Y. R., Phipps, M., Zucker, J., Lebwohl, B., Wang, T. C., Sobieszczyk, M. E., et al. (2020). Gastrointestinal symptoms and coronavirus disease 2019: a case-control study from the United States. Gastroenterology, 159:373-375.e.2. doi: 10.1053/j.gastro.2020.04.017.
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. (2020). Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. The American journal of gastroenterology, 115:766-773. doi: 10.14309/ajg.0000000000000620. PMID: 32287140.
Mao, R., Qiu, Y., He, J. S., Tan, J. Y., Li, X. H., Liang, J., et al. (2020). Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. The lancet Gastroenterology & hepatology, 5:667-678. doi: 10.1016/S2468-1253(20)30126-6.
Wan, Y., Li, J., Shen, L., Zou, Y., Hou, L., Zhu, L., et al. (2020). Enteric involvement in hospitalized patients with COVID-19 outside Wuhan. The lancet Gastroenterology & hepatology, 5:534-535. doi: 10.1016/S2468-1253(20)30118-7.
Patel, H. K., Kovacic, R., Chandrasekar, V. T., Patel, S. C., Singh, M., Le Cam, E., et al. (2022). Correlation of Gastrointestinal Symptoms at Initial Presentation with Clinical Outcomes in Hospitalized COVID-19 Patients: Results from a Large Health System in the Southern USA. Digestive Diseases and Sciences, 7:1-10. doi: 10.1007/s10620-022-07384-0.
Elmunzer, B. J., Spitzer, R. L., Foster, L. D., Merchant, A. A., Howard, E. F., Patel, V. A., et al. (2019). Digestive manifestations in patients hospitalized with coronavirus disease 2019. Clinical gastroenterology and hepatology, 19:1355-1365.e4. doi: 10.1016/j.cgh.2020.09.041.
Aghemo, A., Piovani, D., Parigi, T. L., Brunetta, E., Pugliese, N., Vespa, E., et al. (2020). COVID-19 digestive system involvement and clinical outcomes in a large academic hospital in Milan, Italy. Clinical Gastroenterology and Hepatology,18:2366-2368.e3. doi: 10.1016/j.cgh.2020.05.011.
Blackett, J. W., Li, J., Jodorkovsky, D., & Freedberg, D. E. (2022). Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID‐19. Neurogastroenterology & Motility, 34:e14251. doi: 10.1111/nmo.14251.
Mayer, E. A., Craske, M., & Naliboff, B. D. (2001). Depression, anxiety, and the gastrointestinal system. Journal of Clinical Psychiatry, 62, 28-37.
Choi, E. P. H., Hui, B. P. H., & Wan, E. Y. F. (2020). Depression and anxiety in Hong Kong during COVID-19. International journal of environmental research and public health, 17(10), 3740. doi: 10.3390/ijerph17103740.
Schmulson, M., Ghoshal, U. C., & Barbara, G. (2021). Managing the inevitable surge of post–COVID-19 functional gastrointestinal disorders. Official journal of the American College of Gastroenterology| ACG, 116(1), 4-7. doi: 10.14309/ajg.0000000000001062.
Svedlund, J., Sjödin, I., & Dotevall, G. (1988). GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Digestive diseases and sciences, 33(2), 129-134. doi: 10.1007/BF01535722.
Souza, G. S., Sardá, F. A. H., Giuntini, E. B., Gumbrevicius, I., Morais, M. B. D., & Menezes, E. W. D. (2016). Translation and validation of the brazilian portuguese version of the Gastrointestinal Symptom Rating Scale (GSRS) Questionnaire. Arquivos de Gastroenterologia, 53, 146-151. doi: 10.1590/S0004-28032016000300005.
Scully, E. P., Haverfield, J., Ursin, R. L., Tannenbaum, C., & Klein, S. L. (2020). Considering how biological sex impacts immune responses and COVID-19 outcomes. Nature Reviews Immunology, 20(7), 442-447. doi: 10.1038/s41577-020-0348-8.
de Souza, F. S. H., Hojo-Souza, N. S., Batista, B. D. D. O., da Silva, C. M., & Guidoni, D. L. (2021). On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database. PloS one, 16(3), e0248580. doi: 10.1371/journal.pone.0248580.
Xu, K., Chen, Y., Yuan, J., Yi, P., Ding, C., Wu, W., et al. (2020). Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19). Clinical infectious diseases, 71(15), 799-806. doi: 10.1093/cid/ciaa351.
Zheng, S., Fan, J., Yu, F., Feng, B., Lou, B., Zou, Q., et al. (2020). Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. British medical journal, 369:m1443. doi: 10.1136/bmj.m1443.
Liu, H., Chen, S., Liu, M., Nie, H., & Lu, H. (2020). Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging and disease, 11(3), 668. doi: 10.14336/AD.2020.0502.
Yonekawa, A., & Shimono, N. (2022). Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B. 1.1. 529). Biology, 11(3), 400. doi: 10.3390/biology11030400.
Leung, W. K., To, K. F., Chan, P. K., Chan, H. L., Wu, A. K., Lee, N., et al. (2003). Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology, 125(4), 1011-1017. doi: 10.1016/s0016-5085(03)01215-0.
Rees, E. M., Nightingale, E. S., Jafari, Y., Waterlow, N. R., Clifford, S., B Pearson, C. A., et al. (2020). COVID-19 length of hospital stay: a systematic review and data synthesis. BMC medicine, 18(1), 1-22. doi: 10.1186/s12916-020-01726-3.
Marcolino, M. S., Ziegelmann, P. K., Souza-Silva, M. V., Nascimento, I. J. B. D., Oliveira, L. M., Monteiro, L. S., et al. (2021). Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry. International Journal of infectious diseases, 107, 300-310. doi: 10.1016/j.ijid.2021.01.019.
Rawson, T. M., Moore, L. S., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., ... & Holmes, A. (2020). Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clinical infectious diseases, 71(9), 2459-2468. doi: 10.1093/cid/ciaa530.
Xiao, F., Tang, M., Zheng, X., Liu, Y., Li, X., & Shan, H. (2020). Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology, 158(6), 1831-1833. doi: 10.1053/j.gastro.2020.02.055.
Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., et al. (2003). A major outbreak of severe acute respiratory syndrome in Hong Kong. New England Journal of Medicine, 348(20), 1986-1994. doi: 10.1056/NEJMoa030685.
Zoghi, G., Moosavy, S. H., Yavarian, S., HasaniAzad, M., Khorrami, F., Sharegi Brojeni, M., et al. (2021). Gastrointestinal implications in COVID-19. BMC Infectious Diseases, 21(1), 1-9. doi: 10.1186/s12879-021-06824-y.
Wong, S. H., Lui, R. N., & Sung, J. J. (2020). Covid‐19 and the digestive system. Journal of gastroenterology and hepatology, 35(5), 744-748. doi: 10.1111/jgh.15047.
Giron, L. B., Dweep, H., Yin, X., Wang, H., Damra, M., Goldman, A. R., et al. (2021). Plasma markers of disrupted gut permeability in severe COVID-19 patients. Frontiers in immunology, 12, 686240. doi: 10.3389/fimmu.2021.686240.
Liu, J., Cui, M., Yang, T., & Yao, P. (2020). Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis. BMJ Open Gastroenterol, 7:e000437. doi: 10.1136/bmjgast-2020-000437.
Aiyegbusi, O. L., Hughes, S. E., Turner, G., Rivera, S. C., McMullan, C., Chandan, J. S., et al. (2021). Symptoms, complications and management of long COVID: a review. Journal of the Royal Society of Medicine, 114(9), 428-442. doi: 10.1177/01410768211032850.
Ford, A. C., Sperber, A. D., Corsetti, M., & Camilleri, M. Irritable bowel syndrome. Lancet, 396:1675-1688. doi: 10.1016/S0140-6736(20)31548-8.
Zuo, T., Zhang, F., Lui, G. C., Yeoh, Y. K., Li, A. Y., Zhan, H., et al. (2020). Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology, 159(3), 944-955. doi: 10.1053/j.gastro.2020.05.048.
Kaźmierczak-Siedlecka, K., Vitale, E., & Makarewicz, W. (2020). COVID-19-gastrointestinal and gut microbiota-related aspects. European Review for Medical and Pharmacological Sciences, 24(20), 10853-10859. doi: 10.26355/eurrev_202010_23448.
Noviello, D., Costantino, A., Muscatello, A., Bandera, A., Consonni, D., Vecchi, M., et al. (2022). Functional gastrointestinal and somatoform symptoms five months after SARS‐CoV‐2 infection: A controlled cohort study. Neurogastroenterology & Motility, 34(2), e14187. doi: 10.1111/nmo.14187.
Santos-Júnior, J. C. M. (2005). Constipação intestinal. Revista Brasileira de Coloproctologia, 25:79-93.
Coles, M. J., Masood, M., Crowley, M. M., Hudgi, A., Okereke, C., & Klein, J. (2022). It Ain’t Over'Til It's Over: SARS CoV-2 and Post-infectious Gastrointestinal Dysmotility. Digestive Diseases and Sciences, 1-9. doi: 10.1007/s10620-022-07480.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Suliana Mesquita Paula, Larissa Gurgel Mota Saraiva, Dayllanna Stefanny Lopes Lima Feitosa, Rôney Reis de Castro Silva, Isabela Caldas Borges, Davi Veras Araújo, Sofia Santiago Marinho, Miguel Ângelo Nobre e Souza, Marcellus Henrique Loiola Ponte Souza
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author for more visit Copyright & License.
